PACS Group, Inc. (PACS) AI Stock Analysis

PACS Group, Inc., headquartered in Farmington, Utah, operates skilled nursing facilities and assisted living residences throughout the United States. Established in 2013, the company specializes in senior care services, including independent living facilities. In addition to managing daily facility operations, PACS Group focuses on acquiring, owning, and leasing healthcare-related properties. This comprehensive operating and property investment approach provides specialized accommodation and tailored care solutions designed to address the needs of aging populations across its nationwide network.

Revenue expanded from $1.17B in FY2021 to $5.29B in FY2025, registering a 4-year CAGR of 45.9%. Annual top-line growth was 107.6% in FY2022, 28.5% in FY2023, 31.4% in FY2024, and 29.3% in FY2025. Gross margin stood at 21.9% in FY2025, recovering from 12.4% in FY2024. Operating margin was 5.9% in FY2025, and net income grew to $191.5M with a 3.6% net margin and EPS of $1.75. In the trailing twelve months ending June 30, 2026, revenue totaled $5.55B with an operating margin of 7.7% and EPS of $1.71. For the quarter ended June 30, 2026, quarterly revenue grew 9.1% year-over-year, while quarterly earnings grew 51.6%.

As of June 30, 2026, PACS Group held $164.5M in cash and short-term investments against total debt of $3.25B, resulting in net debt of $3.09B. Shareholders' equity was $1.11B, leading to a debt-to-equity ratio of 2.93 and a current ratio of 0.91. Total assets were $5.66B. In FY2025, operating cash flow reached $404.2M and free cash flow was $298.8M. For capital allocation in FY2025, capital expenditures totaled $105.4M and dividends paid amounted to $33.7M.

PACS trades at a trailing P/E of 27.4x and a forward P/E of 15.5x, compared to medians of 24.6x and 17.3x for its US-listed Healthcare peers. Its enterprise value of $9.59B values the company at an EV/EBITDA of 20.0x versus the peer median of 12.0x, and an EV/revenue of 1.7x. The stock trades at a price-to-sales multiple of 1.3x versus the peer median of 4.1x, and a price-to-book ratio of 5.9x. The PEG ratio is 1.03. Over the past year, PACS achieved a return of 276.8%, compared to 16.8% for the S&P 500 (SPY).

Consensus analyst coverage consists of 4 Strong Buy, 2 Buy, 0 Hold, 0 Sell, and 0 Strong Sell ratings. The mean price target is $59.00, representing 25.8% above the last close of $46.91. For the current fiscal year ending December 31, 2026, analysts estimate EPS of $2.50 (up 38.5%) on revenue of $5.85B. For the next fiscal year, 5 analysts project EPS of $2.74 and revenue of $6.54B. The company beat EPS estimates in 2 of the last 4 quarters. The next earnings date is November 18, 2026.

This page is an AI-written research summary of PACS Group, Inc. (PACS). The text was generated on October 30, 2026 from Quotelinks data as of October 16, 2026 (company profile, annual results, latest balance sheet, valuation, price performance and analyst estimates). An automatic check rejects any draft that contains a figure not found in that data. It is not investment advice; verify figures on the linked tabs before making decisions.

Related: PACS income statement, PACS balance sheet, PACS key metrics, PACS analyst forecast, PACS chart. See the PACS stock overview for the latest quote and news.